A. Lindblad (Savedalen, Sweden), S. Brown (London, United Kingdom), E. Kerem (Jerusalem, Israel), P. Latzin (Bern, Switzerland)
Pulmonary function preservation with targeted antibiotic use in infants with CF
J. Zirbes, C. Milla (Palo Alto, United States Of America)
|  |
KL-6 serum levels in adult cystic fibrosis patients
F. Piffer, A. Airoldi, M. Di Pasquale, G. Pizzamiglio, M. Zanardelli, S. Galbiati, B. Dallari, F. Blasi (Milano, Italy)
| |
Six minute walk test in children, adolescents and young adults with and without cystic fibrosis
F. M. Pereira, M. A. Ribeiro, A. D. Toro, G. Hessel, A. F. Ribeiro, J. D. Ribeiro (Campinas, Brazil)
| |
Exhaled breath temperature in adult cystic fibrosis
G. Garcia, N. Granero, B. Hendriksen, D. Carlos, B. Ezequiel, M. Bergna (La Plata, Vicente Lopez, Argentina)
|  |
Detection of volatile hydrogen cyanide released by pseudomonas aeruginosa with cavity ring down spectroscopy
E. P. M. Verschuren, M. Spunei, S. T. Persijn, S. Cristescu, F. J. M. Harren, J. W. Mouton, P. J. F. M. Merkus (Nijmegen, Delft, Netherlands)
| |
Achromobacter xylosoxidans: Friend or foe?
L. Christiaens, P. Goeminne, L. Dupont (Leuven, Belgium)
| |
Impact of stenotrophomonas maltophilia in cystic fibrosis: A retrospective analysis
E. Dewaele, P. Goeminne, H. Scheers, L. Dupont, P. Van den Brande (Leuven, Belgium)
| |
The role of serum pseudomonas aeruginosa antibodies in diagnosis and follow-up of patients with cystic fibrosis
D. Dogru Ersoz, S. Pekcan, E. Yalcin, U. Ozcelik, N. Kiper, N. Gurcan, B. Sener (Ankara, Konya, Turkey)
| |
Stenotrophomonas maltophilia and achromobacter xylosoxidans in cystic fibrosis patients
S. Gartner, M. Mumany, A. Ferrer, C. Martin, S. Rovira, A. Torrent, I. de Mir, A. Moreno (Barcelona, Spain)
| |
Preventable deaths and better outcomes in CF: Need for organising care at European standards in developing countries
L. L. Dracea, L. Pop (Brasov, Timisoara, Romania)
| |
Genotype-phenotype correlation in cystic fibrosis patients bearing a novel complex allele
R. Tesse, A. Polizzi, T. Santostasi, A. Diana, A. Manca, V. P. Logrillo, L. Cavallo (Bari, Italy)
| |
Twenty years of care for CF patients in Moscow region of Russia
S. Krasovsky, A. Cherniak, E. Amelina, A. Voronkova, N. Kashirskaya, N. Kapranov (Moscow, Russian Federation)
| |
Phenotype and genotype in adult patients with cystic fibrosis in Uruguay
A. Rey, G. Rutz, P. Edilberto, G. Rosario, M. López Varela (Montevideo, Uruguay)
| |
The peculiarities of basic metabolism in cystic fibrosis patients
A. Orlov, A. Pashkevich, L. Jelenina (Saint-Petersburg, Russian Federation)
| |
Evaluation of disease knowledge in children with cystic fibrosis and their families
I. Dicle Sargin, Y. Gokdemir, R. Ersu, B. Karadag, P. Ay, A. Topuzoglu, C. Cimsit, F. Karakoc (Istanbul, Turkey)
| |
An audit to assess the value of the MDT approach in patients in a UK CF unit
M. Gautam, A. Ashish, M. Ledson, J. Naveed, M. Walshaw (Liverpool, United Kingdom)
| |
Improved turn around time for molecular genetic analysis for cystic fibrosis: The Irish experience
F. Flanagan, L. Glackin, D. Slattery (Dublin, Ireland)
| |
Validation of the Spanish version of the Leicester cough questionnaire in children with cystic fibrosis
J. Persegona, T. del Corral, N. López, A. Valiente, M. Garrida, M. Seborga, N. Trujillo, L. Hernandez, J. Villaró (Barcelona, Madrid, Sabadell, Spain)
| |